DarioHealth Corp. (DRIO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
DarioHealth Corp. (DRIO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 2, 2026, Lawrence Leisure notified the Board of Directors (the “Board”) of DarioHealth Corp. (the “Company”) o
How this was made
The 30-second read
Why it matters
The filing provides the first public notice of the director's departure, a routine corporate action with limited market effect.
Market read
Minor corporate governance update; unlikely to drive significant trading activity.
What to watch
Potential hidden reasons for retirement not disclosed; monitor subsequent board appointments.
Background
DarioHealth Corp filed a Form 8‑K reporting a board member's retirement.
Ticker impact
Director Lawrence Leisure retired from the board effective Sep 2, 2026.
minimal short‑term price movement
SEC 8‑K filing is primary source; director departure is routine and unlikely to move the stock significantly.
Market effects
None; corporate governance change does not affect sector trends.
Limited to U.S. investors tracking DarioHealth.
Low; no broader market impact.
Counterpoint
If the departing director held key relationships, his exit could signal upcoming strategic shifts.
Key entities
- CompanyDarioHealth Corp.
Health technology firm listed under ticker DRIO.
- IndividualLawrence Leisure
Departing board member.
